EP 1039903 A1 20001004 - IL-8 RECEPTOR ANTAGONISTS
Title (en)
IL-8 RECEPTOR ANTAGONISTS
Title (de)
IL-8 REZEPTOR ANTAGONISTEN
Title (fr)
ANTAGONISTES DES RECEPTEURS DE L'INTERLEUKINE-8
Publication
Application
Priority
- US 9901029 W 19990115
- US 7165398 P 19980116
Abstract (en)
[origin: WO9936069A1] This invention relates to novel compounds of Formula (I), and compositions therof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
IPC 1-7
IPC 8 full level
A61K 31/428 (2006.01); A61P 1/00 (2006.01); A61P 1/02 (2006.01); A61P 1/04 (2006.01); A61P 7/02 (2006.01); A61P 9/00 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 13/12 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 19/02 (2006.01); A61P 19/08 (2006.01); A61P 19/10 (2006.01); A61P 25/28 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 33/06 (2006.01); A61P 37/06 (2006.01); A61P 43/00 (2006.01); C07D 275/06 (2006.01); C07D 513/04 (2006.01)
CPC (source: EP)
A61P 1/00 (2017.12); A61P 1/02 (2017.12); A61P 1/04 (2017.12); A61P 7/02 (2017.12); A61P 9/00 (2017.12); A61P 11/00 (2017.12); A61P 11/06 (2017.12); A61P 13/12 (2017.12); A61P 17/00 (2017.12); A61P 17/06 (2017.12); A61P 19/02 (2017.12); A61P 19/08 (2017.12); A61P 19/10 (2017.12); A61P 25/28 (2017.12); A61P 31/04 (2017.12); A61P 31/12 (2017.12); A61P 33/06 (2017.12); A61P 37/06 (2017.12); A61P 43/00 (2017.12); C07D 275/06 (2013.01); C07D 513/04 (2013.01)
Designated contracting state (EPC)
BE CH DE ES FR GB IT LI NL
DOCDB simple family (publication)
WO 9936069 A1 19990722; AU 2234199 A 19990802; CA 2318195 A1 19990722; EP 1039903 A1 20001004; EP 1039903 A4 20011205; JP 2002509105 A 20020326
DOCDB simple family (application)
US 9901029 W 19990115; AU 2234199 A 19990115; CA 2318195 A 19990115; EP 99902334 A 19990115; JP 2000539842 A 19990115